Cocaine use in Europe - a multi-centre study: patterns of use in different groups

European Addiction Research
Michael PrinzleveMichael Krausz

Abstract

The study investigates patterns of cocaine powder and crack cocaine use of different groups in nine European cities. Multi-centre cross-sectional study conducted in Barcelona, Budapest, Dublin, Hamburg, London, Paris, Rome, Vienna, and Zurich. Data were collected by structured face-to-face interviews. The sample comprises 1,855 cocaine users out of three subgroups: 632 cocaine users in addiction treatment, mainly maintenance treatment; 615 socially marginalized cocaine users not in treatment, and 608 socially integrated cocaine users not in treatment. Use of cocaine powder, crack cocaine and other substances in the last 30 days, routes of administration, and lifetime use of cocaine powder and crack cocaine. The marginalized group showed the highest intensity of cocaine use, the highest intensity of heroin use and of multiple substance use. 95% of the integrated group snorted cocaine powder, while in the two other groups, injecting was quite prevalent, but with huge differences between the cities. 96% of all participants had used at least one other substance in addition to cocaine in the last 30 days. The use of cocaine powder and crack cocaine varies widely between different groups and between cities. Nonetheless, multiple subs...Continue Reading

Citations

Sep 30, 2006·Wiener klinische Wochenschrift·Andjela BäwertGabriele Fischer
Sep 30, 2006·Wiener klinische Wochenschrift·Christian Haasen, Katja Thane
Sep 2, 2008·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Eugenia Oviedo-JoekesMartin T Schechter
Dec 2, 2008·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Andréa Costa DiasRonaldo Laranjeira
May 19, 2007·Addiction Biology·Antonio Preti
Jan 24, 2006·BMC Public Health·Camila GuindaliniRonaldo Laranjeira
Mar 13, 2008·European Addiction Research·G Niveau, C Ritter
Sep 11, 2010·Drug and Alcohol Dependence·Louisa DegenhardtWayne D Hall
Feb 2, 2010·The International Journal on Drug Policy·Vicky BungaySusan Boyd
Nov 18, 2008·The International Journal on Drug Policy·Patrick McCrystal, Andrew Percy
Jun 17, 2008·The International Journal on Drug Policy·Agnes van der PoelDike van de Mheen
Apr 24, 2013·Substance Use & Misuse·Raimondo Maria Pavarin
Dec 2, 2014·Traffic Injury Prevention·Rossella SnenghiSanto Davide Ferrara
Oct 26, 2006·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Marcelo RibeiroRonaldo Laranjeira
Apr 22, 2009·Toxicologic Pathology·Percyleine P HerculianiThais Mauad
Aug 29, 2017·Journal of Psychoactive Drugs·Raimondo Maria Pavarin, Angelo Fioritti
Jan 18, 2008·Addiction·M Jesús HerreroUNKNOWN ITINERE Investigators
Jun 6, 2009·European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine·Walter de MillasIngo Schaefer
Jun 23, 2010·Drug and Alcohol Review·Dan WerbEvan Wood
Mar 7, 2019·Journal of Psychoactive Drugs·Ansgar Rougemont-BückingJoseph Studer
Jun 14, 2012·The American Journal on Addictions·Felix Henrique Paim KesslerFlavio Pechansky
Jun 27, 2013·Addiction Biology·Katrin H PrellerBoris B Quednow
Dec 19, 2019·Revista brasileira de enfermagem·Jessica Adrielle Teixeira SantosSandra Cristina Pillon
Feb 14, 2014·Addiction·José PulidoUNKNOWN Itinere Working Group
Aug 19, 2007·Drug and Alcohol Review·James ShearerLinette Collins

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.